Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.lungcan.2020.12.012 http://scihub22266oqcxt.onion/10.1016/j.lungcan.2020.12.012 33373838!7832712!33373838     free     free     free       Lung+Cancer 2021 ; 152 (ä): 98-103 Nephropedia Template TP {{tp|p=33373838|t=2021. Cancer treatment in the coronavirus disease pandemic |pdf=|usr=}}{{33373838}} gab.com Text Cancer treatment in the coronavirus disease pandemic JO: Lung Cancer http://www.kidney.de/pget.php?&tw=1&pmid=33373838 #FOAvip Half a year after its emergence, severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) has resulted in a pandemic, with cases continuing to increase in nearly every country. Surges in coronavirus disease of 2019 (COVID-19) cases have clearly had profound effects on current cancer treatment paradigms. Considering the effect of antineoplastic treatment and the immunosuppressive properties of cancer itself, cancer patients are deemed to be more vulnerable to SARS-CoV-2. Hence, the specific risk of SARS-CoV-2 must be carefully weighed against the benefit of antineoplastic treatment for cancer patients in the COVID-19 era. In this review, we discuss the current evidence in this important field, and in particular, the effect of SARS-CoV-2 on antineoplastic treatment. Twit Text FOAVip Cancer treatment in the coronavirus disease pandemic ????Lung Cancer http://www.kidney.de/pget.php?&tw=1&pmid=33373838 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33373838 #FOAvip English Wikipedia <ref>{{Cite pmid|33373838}}</ref> Cancer treatment in the coronavirus disease pandemic #MMPMID33373838 Zhang JT; Zhong WZ; Wu YL Lung Cancer 2021[Feb]; 152 (ä): 98-103 PMID33373838show ga Half a year after its emergence, severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) has resulted in a pandemic, with cases continuing to increase in nearly every country. Surges in coronavirus disease of 2019 (COVID-19) cases have clearly had profound effects on current cancer treatment paradigms. Considering the effect of antineoplastic treatment and the immunosuppressive properties of cancer itself, cancer patients are deemed to be more vulnerable to SARS-CoV-2. Hence, the specific risk of SARS-CoV-2 must be carefully weighed against the benefit of antineoplastic treatment for cancer patients in the COVID-19 era. In this review, we discuss the current evidence in this important field, and in particular, the effect of SARS-CoV-2 on antineoplastic treatment. |*COVID-19[MESH] |Antineoplastic Agents/*therapeutic use[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Neoplasms/*drug therapy/epidemiology/*virology[MESH] |Prevalence[MESH]Cancer treatment in the coronavirus disease pandemic (epmc).pdf DeepDyve Pubget Overpricing